SANTA BARBARA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- AppFolio, (NASDAQ:APPF), a technology leader powering the future of the real estate industry, today announced that it will host an investor meeting on Tuesday, November 18, 2025. AppFolio President and Chief Executive Officer Shane Trigg and AppFolio Chief Financial Officer Tim Eaton, as well as other members of AppFolio’s senior leadership team, will host presentations on AppFolio’s strategy for growth and how it is shaping the future of real estate, ...

– Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination studies with RAS(ON) inhibitors ongoing, data anticipated 2026 – – 49% ORR and mPFS 9.1 months in histology selective cohort of multiple late line, difficult to treat cancers provide further evidence of strong activity – – $225 million in gross proceeds from October 2025 financing extends cash runway into 2028 – BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Tango Th ...

National quarterly survey reveals that healthcare, tariffs, and financing costs are top challenges shaping business decisions for middle-market leadersCleveland, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cost pressures are amongst the top concerns for mid-market leaders according to the latest CBIZ Mid-Market Pulse. CBIZ, Inc., a leading national professional services advisor, released its latest quarterly survey and analysis of business sentiment. The report details how mid-market companies are entering 2026 with ...

核心观点 - 公司通过其投资的子公司Neologics与合同研究组织GemPharmatech达成关键服务协议，标志着公司全球扩张和业务多元化战略的重要里程碑，并显示其战略从资本注入向研发执行的高效转变 [1] 合作协议详情 - 协议规定Neologics作为独立承包商为GemPharmatech提供特定测试服务，服务范围涵盖从材料制备、血清滴度分析、杂交瘤融合与筛选、抗体测序与生产到体外验证的完整流程 [2] - 作为对价，GemPharmatech同意就协议相关的工作订单向Neologics支付总计114,000美元 [2] 子公司Neologics概况 - Neologics是一家专注于研发服务的医疗技术公司，成立于2021年，在加州圣地亚哥设有实验室和研发中心 [3] - 公司专注于与大学、医院、研究机构和生物技术公司进行研发合作，并定位于人工智能与医学的交叉领域，旨在通过整合多维生物数据资源的独立研发平台，开发药物筛选、靶点发现和临床前验证的系统性解决方案 [3] - 公司于2025年10月21日公开宣布对Neologics投资100万美元，截至2025年10月29日，Neologics已完成股东登记，确认公司持有其10%的股权 [3] 合作伙伴GemPharmatech概况 - GemPharmatech是一家为全球科学界提供基因工程小鼠模型和临床前研究服务的合同研究组织 [4] - 公司专注于利用尖端基因编辑技术开发先进动物模型，并拥有一个包含基因敲除、条件性基因敲除、人源化、免疫缺陷和无菌小鼠的广泛资源库 [4] 管理层评论 - 公司首席执行官兼董事会主席评论此次合作是与GemPharmatech建立伙伴关系的良好开端，预计将加速Neologics的业务发展，并强化公司的战略多元化及与全球同行的联系 [5] - 公司预期其多元化和全球整合的战略将成功利用其深厚的行业专业知识，加速转型进程，驱动长期强劲增长并为所有利益相关者释放价值 [5] 公司业务概览 - 公司是一家医疗设备供应商，在中国开发和生产I类和II类医疗设备，并通过在中国的运营子公司销售I类和II类一次性医疗设备 [6] - 公司拥有包含21种产品的多元化产品组合，产品已销往中国34个省级行政区，其中15种产品销往全球超过30个国家 [6] - 公司已获得多项质量相关的制造认证，并有17种产品在美国食品药品监督管理局注册，获准进入美国市场 [6]

SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- OMNIQ CORP. (OTCMKTS: OMQS) (“OMNIQ” or “the Company”), a leader in AI-based computer vision and data intelligence, is chosen by a public research university in Wisconsin to implement advanced access-control technology across campus facilities and parking areas. The project aims to support safer, more efficient daily operations through automated credentialing, role-based permissions, and centralized management. Serving approximately 50,000 students and 27,00 ...

SFL Corporation Ltd. ("SFL" or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the third quarter of 2025 on Tuesday, November 11, 2025. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Tuesday, November 11, 2025, at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will on the same day be available from the Investor Relations section of the Company’s website at www.sflcorp.com. In order to listen to the conference call and prese ...

HAUPPAUGE, N.Y., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Orbit International Corp. (the “Company”) (OTCID Basic Market:ORBT), an electronics manufacturer and software solution provider, today announced that its Simulator Product Solutions LLC (“SPS”) subsidiary recorded bookings in excess of $1,000,000 for the month of October 2025. Deliveries for orders received during the month are expected to commence in the fourth quarter of 2025 and are expected to continue through the third quarter of 2026. Mitchell Binder, ...

MIDDLETOWN, R.I., Nov. 04, 2025 (GLOBE NEWSWIRE) -- KVH Industries, Inc. (Nasdaq: KVHI), will announce its financial results for the third quarter that ended on September 30, 2025, on Thursday, November 6, 2025. In conjunction with the release, the company will conduct its investor conference call at 9:00 a.m. ET, hosted by Mr. Brent Bruun, CEO, and Mr. Anthony Pike, CFO. A live broadcast of the call will be available online at investors.kvh.com. In addition, an audio replay of the conference call will be a ...

OTTAWA and SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, today announced an expanded relationship with Farcast, a San Francisco-based startup that is building advanced satellite User Terminals. Under the new agreement, Farcast will deliver an enterprise-class Flat Panel Antenna (FPA) User Terminal that is fully integrated with the Telesat Lightspeed modem and ready for volume production. Additionally, Tele ...

New FDA feedback confirms clinical pathway for fixed multi-phage cocktail BX011, expanding development into diabetic foot infections (DFI) and unlocking a major commercial opportunityNESS ZIONA, Israel, Nov. 04, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that it has received positive feedback from the U.S. Food and Drug Administrat ...